Review Article
Chinese Herbal Medicine for Aspirin Resistance: A Systematic Review of Randomized Controlled Trials
Table 3
The methodological quality of included studies.
| | | A | B | C | D | E | F | G | H | I | J | K | L | Total + | Total − | Total ? |
| | Peng et al. 2011 [33] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | | Ma et al. 2012 [34] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | | Su 2012 [35] | + | − | − | − | − | ? | + | ? | + | + | ? | + | 5 | 4 | 2 | | Guo 2012 [36] | ? | − | − | − | − | ? | − | ? | + | + | ? | + | 3 | 5 | 3 | | Chai et al. 2008 [37] | ? | − | − | − | − | ? | ? | ? | − | + | ? | + | 2 | 5 | 5 | | Chen et al. 2008 [38] | + | + | − | − | − | ? | + | ? | + | + | ? | + | 6 | 4 | 3 | | Zhang et al. 2010 [39] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 6 | | Yin et al. 2010 [40] | + | − | − | − | − | ? | + | ? | + | + | + | + | 5 | 4 | 3 | | Song et al. 2008 [41] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | | Wu 2012 [43] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | Liu
2010 [67] | + | − | − | − | − | ? | + | ? | + | + | ? | + | 5 | 4 | 2 | | Liu 2008 [45] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | | Cheng et al. 2010 [46] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | | Liu et al. 2006 [47] | ? | − | − | − | − | ? | + | ? | + | + | ? | + | 4 | 4 | 4 | | Sun et al. 2009 [48] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 | | Luo et al. 2012 [49] | ? | − | − | − | − | ? | ? | ? | + | + | ? | + | 3 | 4 | 5 |
|
|
A: adequate sequence generation; B: concealment of allocation; C: blinding (patient); D: blinding (investigator); E: blinding (assessor); F: incomplete outcome data addressed (ITT analysis); G: incomplete outcome data addressed (dropouts); H: free of selective reporting; I: similarity at baseline; J: cointerventions constant; K: compliance acceptable; L: similar timing outcome assessments. +: yes, −: no, and ?: unclear.
|
